Probiotic Supplement in Older Adults With Prediabetes
Tests a probiotic supplement in people aged 65 and older with prediabetes.
Plain-language title generated from the registry record
Registry title: Development of Smart Food /Nutraceutical Solutions Dedicated to Cardiometabolic Disorders in Ageing
Key facts
- Where
- Novara, ItalySee the site
Where in Italy
- SCDU Endocrinology, AOU Ospedale Maggiore della CaritàNovara, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Azienda Ospedaliero Universitaria Maggiore della Carita
- Trial code
- NCT07817290
- Record updated
- 14 September 2026
- Original description
Describe the anthropometric measurements and informations relating to body composition, blood chemistry tests, blood glucose monitoring, and dietary habits of the volunteers participating in the study before and after taking probiotics.Read full original descriptionShow less
NUTRI.AGE: DEVELOPMENT OF SMART FOOD/NUTRACEUTICAL SOLUTIONS DEDICATED TO CARDIOMETABOLIC DISORDERS IN AGEING
Describe the anthropometric measurements and informations relating to body composition, blood chemistry tests, blood glucose monitoring, and dietary habits of the volunteers participating in the study before and after taking probiotics.
Inclusion: Patients of either gender, over 65 years of age, able to understand the protocol procedures; Known cardiovascular disease; Prediabetes or type 2 diabetes mellitus with HbA1c < 7.0% on diet alone or metformin.
Exclusion: Previous diagnosis of type 2 diabetes mellitus already undergoing drug therapy (except metformin); Arterial hypertension treated with an ACE inhibitor or ARB; Previous bariatric surgery; Contraindications such as allergy to product components; Obesity secondary to diseases: genetic (Prader-Willi syndrome, Down syndrome); metabolic and endocrine (Cushing's syndrome, hypothyroidism); Endocrine or liver disease or clinical evidence of chronic disease or gastrointestinal disorders or malabsorption disorders; History of adrenal adenoma or secondary arterial hypertension due to renal/adrenal causes; Age under 65.